|Bid||33.27 x 6100|
|Ask||33.28 x 11000|
|Day's Range||33.08 - 33.39|
|52 Week Range||29.83 - 35.38|
|PE Ratio (TTM)||28.03|
|Dividend & Yield||1.28 (3.91%)|
|1y Target Est||N/A|
A federal appeals court on Wednesday upheld the insider trading conviction of Mathew Martoma, a former portfolio manager for billionaire Steven A. Cohen's SAC Capital Advisors LP, after the U.S. Supreme Court made such cases easier to pursue. In a 2-1 vote, the 2nd U.S. Circuit Court of Appeals in Manhattan found "overwhelming" evidence that a Michigan doctor received financial benefits from providing confidential information to Martoma about a 2008 Alzheimer's drug trial.
Pfizer, Inc. (PFE) and six international cancer research groups are collaborating on a combination study to explore the use of Ibrance for first-line treatment of advanced breast cancer.
A divided federal appeals court on Wednesday upheld the insider trading conviction of Mathew Martoma, a former SAC Capital Advisors LP portfolio manager, rejecting his claims that there was inadequate ...